Research
Hormonal
Obesity negatively impacts ovarian stimulation and is associated with reproductive disorders.
Addressing obesity may improve fertility treatment outcomes.
StrongSupportsmedium confidence
Obesity has been widely recognised as a significant factor that negatively impacts ovarian stimulation in women and is associated with several reproductive disorders.
Why this rating
The claim is based on a synthesis of current evidence.
Source
COMMENTARY PART 2: WEIGHT LOSS INTERVENTIONS FOR IMPROVING FERTILITYA SYNTHESIS OF CURRENT EVIDENCE
Emma Schneider et al. · The Practising Midwife · 2024
DOI 10.55975/qltp8768
reviewCited 2×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →